COVANCE TO EXPAND INDUSTRY-LEADING FOOD & NUTRACEUTICAL TESTING SERVICES
Facility enhancements will strengthen Covance's position in growing food and nutraceutical industry |
|
Princeton, New Jersey, August 8, 2001 — Covance Inc. (NYSE: CVD) today announced that it will expand its food and nutraceutical laboratories as part an overall expansion project of its operations in Madison, Wisconsin, which is expected to be completed in the fourth quarter of 2002. This move will provide Covance with the facilities necessary to support existing products and an anticipated stream of new products entering the conventional food and nutraceutical markets. As a leader in food safety and nutritional testing, Covance's scientists help food manufacturers navigate the path from development to product release by providing accurate scientific data and dependable regulatory expertise. From nutritional analysis and labeling to stability testing and clinical studies of dietary supplements, Covance adapts to clients' needs by offering complete product evaluation or single nutrient assays.
"Covance has been a leader in food and nutritional testing for more than 60 years and offers the most comprehensive range of research and testing services available in this area," said Wendel Barr, Vice President and General Manager, Covance Laboratories. "With this latest move, Covance will have 20% more capacity in our North American food and nutraceutical operations and a purpose-built facility designed to match the process flow of a sample from accession to final reporting, leading to faster turnaround times and improved customer service."
Covance is also proud to announce that it has recently received from the American Association of Cereal Chemists (AACC) three of its 2000 Accuracy Awards. Specifically, Covance was awarded for Check Sample Series VMP (analysis of Vitamins, Minerals, and Proximates), Series SA (Sugars by HPLC), and Series DF (Dietary Fiber). These prestigious awards are based on an internationally recognized scale of accuracy and precision among all AACC check sample subscribers for the year 2000. For more information on AACC International Check Sample and Proficiency Testing Service, please visit www.aaccnet.org/checksample.
Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with 2000 pro forma revenues of $737 million, operations currently in 17 countries, and approximately 7,100 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through the website in the About Covance area. |
|
|
